Literature DB >> 9212751

Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau.

K Islam1, E Levy.   

Abstract

Alzheimer's disease is a neurodegenerative disorder characterized by protein depositions in intracellular and extracellular spaces in the brain. The intraneuronal deposits are formed by neurofibrillary tangles composed mainly of abnormally phosphorylated tau, a microtubule-associated protein, whereas the major constituent of the amyloid deposited extracellularly in the brain parenchyma and vessel walls is amyloid beta-protein (A beta). The proteolytic processing of the beta-amyloid precursor protein (beta PP) results in the generation of a complex set of carboxyl-terminal peptides that contain A beta. In this study, we have used fusion proteins containing carboxyl-terminal fragments of beta PP to investigate the association of beta PP with cellular components. We demonstrate that specific domains within the carboxyl end of beta PP contain binding sites for cytoskeletal components; one, within residues 1 to 28 of A beta, binds directly to tubulin, and the second one, within sequences carboxyl-terminal to A beta, binds tau and tubulin. We propose that the two neuropathological hallmarks of Alzheimer's disease, A beta deposition and neurofibrillary tangles, represent the residual of a disrupted beta PP-tubulin-tau complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212751      PMCID: PMC1857905     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  The amyloid percursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types.

Authors:  L Autilio-Gambetti; A Morandi; M Tabaton; B Schaetzle; D Kovacs; G Perry; S Sharma; J Cornette; B Greenberg; P Gambetti
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

2.  A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles.

Authors:  B T Hyman; G W Van Hoesen; K Beyreuther; C L Masters
Journal:  Neurosci Lett       Date:  1989-07-03       Impact factor: 3.046

3.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

4.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

5.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

6.  beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease.

Authors:  G Giaccone; B Pedrotti; A Migheli; L Verga; J Perez; G Racagni; M A Smith; G Perry; L De Gioia; C Selvaggini; M Salmona; J Ghiso; B Frangione; K Islam; O Bugiani; F Tagliavini
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

Authors:  R E Tanzi; A I McClatchey; E D Lamperti; L Villa-Komaroff; J F Gusella; R L Neve
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

8.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

9.  Solubilization of full-length amyloid precursor proteins from PC12 cell membranes.

Authors:  J A Ripellino; D Vassilacopoulou; N K Robakis
Journal:  J Neurosci Res       Date:  1994-10-01       Impact factor: 4.164

10.  Familial Alzheimer's disease cells abnormally accumulate beta-amyloid-harbouring peptides preferentially in cytosol but not in extracellular fluid.

Authors:  A Matsumoto; R Matsumoto
Journal:  Eur J Biochem       Date:  1994-11-01
View more
  9 in total

1.  Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration.

Authors:  Dolores Del Prete; Richard C Rice; Anjali M Rajadhyaksha; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

2.  The transmembrane amyloid precursor C99 protein exhibits non-specific interaction with tau.

Authors:  Rhett J Britton; James M Hutchison; Charles R Sanders
Journal:  Biochem Biophys Res Commun       Date:  2021-08-30       Impact factor: 3.322

3.  Localizations of endogenous APP/APP-proteolytic products are consistent with microtubular transport.

Authors:  Galynn Zitnik; Lin Wang; George M Martin; Qubai Hu
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

4.  A betaPP peptide carboxyl-terminal to Abeta is neurotoxic.

Authors:  G Marcon; G Giaccone; B Canciani; L Cajola; G Rossi; L De Gioia; M Salmona; O Bugiani; F Tagliavini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane.

Authors:  Yasuhiro Yamamoto; Kenkichi Takase; Junji Kishino; Megumi Fujita; Noboru Okamura; Toshiyuki Sakaeda; Masafumi Fujimoto; Tatsurou Yagami
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 6.  The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.

Authors:  Bruce X Wong; James A Duce
Journal:  Front Pharmacol       Date:  2014-04-21       Impact factor: 5.810

7.  LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.

Authors:  Daniela Puzzo; Roberto Piacentini; Mauro Fá; Walter Gulisano; Domenica D Li Puma; Agnes Staniszewski; Hong Zhang; Maria Rosaria Tropea; Sara Cocco; Agostino Palmeri; Paul Fraser; Luciano D'Adamio; Claudio Grassi; Ottavio Arancio
Journal:  Elife       Date:  2017-07-11       Impact factor: 8.140

Review 8.  Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.

Authors:  Mercedes Unzeta; Gerard Esteban; Irene Bolea; Wieslawa A Fogel; Rona R Ramsay; Moussa B H Youdim; Keith F Tipton; José Marco-Contelles
Journal:  Front Neurosci       Date:  2016-05-25       Impact factor: 4.677

Review 9.  Synaptic tau: A pathological or physiological phenomenon?

Authors:  Miranda Robbins; Emma Clayton; Gabriele S Kaminski Schierle
Journal:  Acta Neuropathol Commun       Date:  2021-09-09       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.